Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye

• Status: Completed
• Trial end date: 2003-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Comparative efficacy trial of INS365 Ophthalmic Solution and placebo in patients with dry eye.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Ophthalmic Solutions; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• have Non-Sjogren's associated dry eye disease with symptoms lasting greater than 6 months

• had intermittent or regular artificial tear use within past 3 months

Exclusion Criteria:

• had LASIK surgery

• had punctal occlusion or cauterization within last 3 months